ReviewFrontiers in immunology2018

Genetically Engineered T-Cells for Malignant Glioma: Overcoming the Barriers to Effective Immunotherapy.

Pavlina Chuntova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.